PharmEasy gets $300 million booster shot for Thyrocare deal
Bengaluru: PharmEasy has raised $300 million more, led by its existing investors, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostic chain Thyrocare, a top executive told ET. US private equity major TPG, Singapore’s Temasek, Facebook cofounder … Read more